Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells.
Cardiovascular progenitor cells (CPCs) have been identified within the developing mouse heart and differentiating pluripotent stem cells by intracellular transcription factors Nkx2.5 and Islet 1 (Isl1). Study of endogenous and induced pluripotent stem cell (iPSC)-derived CPCs has been limited due to...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3467279?pdf=render |
id |
doaj-fde20397c85f45dd9483e83406869170 |
---|---|
record_format |
Article |
spelling |
doaj-fde20397c85f45dd9483e834068691702020-11-25T00:44:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4560310.1371/journal.pone.0045603Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells.Ali NsairKatja Schenke-LaylandBen Van HandelDenis EvseenkoMichael KahnPeng ZhaoJoseph MendelisSanaz HeydarkhanObina AwajiMiriam VottlerSusanne GeistJennifer ChyuNuria Gago-LopezGay M CrooksKathrin PlathJosh GoldhaberHanna K A MikkolaW Robb MacLellanCardiovascular progenitor cells (CPCs) have been identified within the developing mouse heart and differentiating pluripotent stem cells by intracellular transcription factors Nkx2.5 and Islet 1 (Isl1). Study of endogenous and induced pluripotent stem cell (iPSC)-derived CPCs has been limited due to the lack of specific cell surface markers to isolate them and conditions for their in vitro expansion that maintain their multipotency.We sought to identify specific cell surface markers that label endogenous embryonic CPCs and validated these markers in iPSC-derived Isl1(+)/Nkx2.5(+) CPCs. We developed conditions that allow propagation and characterization of endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPCs and protocols for their clonal expansion in vitro and transplantation in vivo. Transcriptome analysis of CPCs from differentiating mouse embryonic stem cells identified a panel of surface markers. Comparison of these markers as well as previously described surface markers revealed the combination of Flt1(+)/Flt4(+) best identified and facilitated enrichment for Isl1(+)/Nkx2.5(+) CPCs from embryonic hearts and differentiating iPSCs. Endogenous mouse and iPSC-derived Flt1(+)/Flt4(+) CPCs differentiated into all three cardiovascular lineages in vitro. Flt1(+)/Flt4(+) CPCs transplanted into left ventricles demonstrated robust engraftment and differentiation into mature cardiomyocytes (CMs).The cell surface marker combination of Flt1 and Flt4 specifically identify and enrich for an endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPC with trilineage cardiovascular potential in vitro and robust ability for engraftment and differentiation into morphologically and electrophysiologically mature adult CMs in vivo post transplantation into adult hearts.http://europepmc.org/articles/PMC3467279?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ali Nsair Katja Schenke-Layland Ben Van Handel Denis Evseenko Michael Kahn Peng Zhao Joseph Mendelis Sanaz Heydarkhan Obina Awaji Miriam Vottler Susanne Geist Jennifer Chyu Nuria Gago-Lopez Gay M Crooks Kathrin Plath Josh Goldhaber Hanna K A Mikkola W Robb MacLellan |
spellingShingle |
Ali Nsair Katja Schenke-Layland Ben Van Handel Denis Evseenko Michael Kahn Peng Zhao Joseph Mendelis Sanaz Heydarkhan Obina Awaji Miriam Vottler Susanne Geist Jennifer Chyu Nuria Gago-Lopez Gay M Crooks Kathrin Plath Josh Goldhaber Hanna K A Mikkola W Robb MacLellan Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. PLoS ONE |
author_facet |
Ali Nsair Katja Schenke-Layland Ben Van Handel Denis Evseenko Michael Kahn Peng Zhao Joseph Mendelis Sanaz Heydarkhan Obina Awaji Miriam Vottler Susanne Geist Jennifer Chyu Nuria Gago-Lopez Gay M Crooks Kathrin Plath Josh Goldhaber Hanna K A Mikkola W Robb MacLellan |
author_sort |
Ali Nsair |
title |
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. |
title_short |
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. |
title_full |
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. |
title_fullStr |
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. |
title_full_unstemmed |
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. |
title_sort |
characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
Cardiovascular progenitor cells (CPCs) have been identified within the developing mouse heart and differentiating pluripotent stem cells by intracellular transcription factors Nkx2.5 and Islet 1 (Isl1). Study of endogenous and induced pluripotent stem cell (iPSC)-derived CPCs has been limited due to the lack of specific cell surface markers to isolate them and conditions for their in vitro expansion that maintain their multipotency.We sought to identify specific cell surface markers that label endogenous embryonic CPCs and validated these markers in iPSC-derived Isl1(+)/Nkx2.5(+) CPCs. We developed conditions that allow propagation and characterization of endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPCs and protocols for their clonal expansion in vitro and transplantation in vivo. Transcriptome analysis of CPCs from differentiating mouse embryonic stem cells identified a panel of surface markers. Comparison of these markers as well as previously described surface markers revealed the combination of Flt1(+)/Flt4(+) best identified and facilitated enrichment for Isl1(+)/Nkx2.5(+) CPCs from embryonic hearts and differentiating iPSCs. Endogenous mouse and iPSC-derived Flt1(+)/Flt4(+) CPCs differentiated into all three cardiovascular lineages in vitro. Flt1(+)/Flt4(+) CPCs transplanted into left ventricles demonstrated robust engraftment and differentiation into mature cardiomyocytes (CMs).The cell surface marker combination of Flt1 and Flt4 specifically identify and enrich for an endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPC with trilineage cardiovascular potential in vitro and robust ability for engraftment and differentiation into morphologically and electrophysiologically mature adult CMs in vivo post transplantation into adult hearts. |
url |
http://europepmc.org/articles/PMC3467279?pdf=render |
work_keys_str_mv |
AT alinsair characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT katjaschenkelayland characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT benvanhandel characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT denisevseenko characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT michaelkahn characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT pengzhao characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT josephmendelis characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT sanazheydarkhan characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT obinaawaji characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT miriamvottler characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT susannegeist characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT jenniferchyu characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT nuriagagolopez characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT gaymcrooks characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT kathrinplath characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT joshgoldhaber characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT hannakamikkola characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells AT wrobbmaclellan characterizationandtherapeuticpotentialofinducedpluripotentstemcellderivedcardiovascularprogenitorcells |
_version_ |
1725275125197045760 |